{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T06:00:06Z","timestamp":1791525606824,"version":"4.3.4"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T00:00:00Z","timestamp":1736899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T00:00:00Z","timestamp":1736899200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100008270","name":"Warwara Larsens Fond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008270","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008269","name":"L\u00e6ge Sophus Carl Emil Friis og hustru Olga Doris Friis' Legat","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008269","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Central Region of Denmark"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2025,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Although optic neuritis (ON) is common in multiple sclerosis (MS), lesions of the optic nerve are not included as an anatomical substrate for dissemination in space and time (DIS and DIT).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Objective<\/jats:title>\n            <jats:p>To assess the increase in sensitivity of including MRI lesions of the optic nerve for the diagnosis of MS in patients with ON.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We included patients consecutively referred with first time, monosymptomatic ON, with no known cause of the ON, who underwent orbital MRI including fat suppressed T2 and T1-sequences with and without gadolinium contrast.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>One hundred and twenty patients were included. Optic nerve T2 lesions and\/or T1-contrast enhancement was shown in 104 patients. Sixty-three patients were diagnosed with MS at baseline. Nine patients developed MS during follow-up. The inclusion of optic nerve MRI lesions led to the diagnosis of 8 additional patients and increased sensitivity to 0.99 (95% CI 0.96\u20131.00) compared to 0.88 (95% CI 0.79\u20130.95) for 2017 criteria, while decreasing the specificity to 0.81 (95% CI 0.70\u20130.92) compared to 1.00.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Amending the diagnostic criteria for MS to include MRI lesions of the optic nerve as a substrate for DIS and DIT may increase sensitivity and lead to more rapid diagnosis of MS.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s00415-024-12801-7","type":"journal-article","created":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T13:24:38Z","timestamp":1736947478000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["The value of magnetic resonance imaging of the optic nerve for the diagnosis of multiple sclerosis in patients with optic neuritis"],"prefix":"10.1007","volume":"272","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2596-9358","authenticated-orcid":false,"given":"Gorm","family":"Pihl-Jensen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jette Lautrup","family":"Frederiksen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,15]]},"reference":[{"key":"12801_CR1","volume-title":"McAlpine\u2019s multiple sclerosis","author":"A Compston","year":"2005","unstructured":"Compston A et al (2005) McAlpine\u2019s multiple sclerosis, 4th edn. Churchill Livingstone, Edinburgh","edition":"4"},{"issue":"2","key":"12801_CR2","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/s1474-4422(17)30470-2","volume":"17","author":"AJ Thompson","year":"2018","unstructured":"Thompson AJ et al (2018) Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 17(2):162\u2013173. https:\/\/doi.org\/10.1016\/s1474-4422(17)30470-2","journal-title":"Lancet Neurol"},{"issue":"1","key":"12801_CR3","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/s1474-4422(13)70259-x","volume":"13","author":"AT Toosy","year":"2014","unstructured":"Toosy AT, Mason DF, Miller DH (2014) Optic neuritis. Lancet Neurol 13(1):83\u201399. https:\/\/doi.org\/10.1016\/s1474-4422(13)70259-x","journal-title":"Lancet Neurol"},{"issue":"3","key":"12801_CR4","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1212\/wnl.53.3.473","volume":"53","author":"TL Sorensen","year":"1999","unstructured":"Sorensen TL, Frederiksen JL, Bronnum-Hansen H, Petersen HC (1999) Optic neuritis as onset manifestation of multiple sclerosis: a nationwide, long-term survey. Neurology 53(3):473\u2013478. https:\/\/doi.org\/10.1212\/wnl.53.3.473","journal-title":"Neurology"},{"issue":"6","key":"12801_CR5","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1001\/archneur.65.6.727","volume":"65","author":"MC Brodsky","year":"2008","unstructured":"Brodsky MC et al (2008) Multiple sclerosis risk after optic neuritis: final optic neuritis treatment trial follow-up. Arch Neurol 65(6):727\u2013732. https:\/\/doi.org\/10.1001\/archneur.65.6.727","journal-title":"Arch Neurol"},{"issue":"13","key":"12801_CR6","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1177\/1352458514542862","volume":"20","author":"EH Martinez-Lapiscina","year":"2014","unstructured":"Martinez-Lapiscina EH et al (2014) The visual pathway as a model to understand brain damage in multiple sclerosis. Mult Scler 20(13):1678\u20131685. https:\/\/doi.org\/10.1177\/1352458514542862","journal-title":"Mult Scler"},{"key":"12801_CR7","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awf087","author":"MJ Kupersmith","year":"2002","unstructured":"Kupersmith MJ, Alban T, Zeiffer B, Lefton D (2002) Contrast-enhanced MRI in acute optic neuritis: relationship to visual performance. Brain. https:\/\/doi.org\/10.1093\/brain\/awf087","journal-title":"Brain"},{"key":"12801_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0113961","author":"S Berg","year":"2015","unstructured":"Berg S et al (2015) Baseline magnetic resonance imaging of the optic nerve provides limited predictive information on short-term recovery after acute optic neuritis. PLoS ONE. https:\/\/doi.org\/10.1371\/journal.pone.0113961","journal-title":"PLoS ONE"},{"issue":"12","key":"12801_CR9","doi-asserted-by":"publisher","first-page":"e1130","DOI":"10.1212\/wnl.0000000000006207","volume":"91","author":"WJ Brownlee","year":"2018","unstructured":"Brownlee WJ, Miszkiel KA, Tur C, Barkhof F, Miller DH, Ciccarelli O (2018) Inclusion of optic nerve involvement in dissemination in space criteria for multiple sclerosis. Neurology 91(12):e1130\u2013e1134. https:\/\/doi.org\/10.1212\/wnl.0000000000006207","journal-title":"Neurology"},{"issue":"2","key":"12801_CR10","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/s1474-4422(17)30469-6","volume":"17","author":"M Filippi","year":"2018","unstructured":"Filippi M et al (2018) Prediction of a multiple sclerosis diagnosis in patients with clinically isolated syndrome using the 2016 MAGNIMS and 2010 McDonald criteria: a retrospective study. Lancet Neurol 17(2):133\u2013142. https:\/\/doi.org\/10.1016\/s1474-4422(17)30469-6","journal-title":"Lancet Neurol"},{"key":"12801_CR11","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000207805","author":"A Vidal-Jordana","year":"2024","unstructured":"Vidal-Jordana A et al (2024) Adding the optic nerve in multiple sclerosis diagnostic criteria: a longitudinal, prospective, multicenter study. Neurology. https:\/\/doi.org\/10.1212\/WNL.0000000000207805","journal-title":"Neurology"},{"issue":"8","key":"12801_CR12","doi-asserted-by":"publisher","first-page":"E784","DOI":"10.1212\/WNL.0000000000207507","volume":"101","author":"G Bsteh","year":"2023","unstructured":"Bsteh G et al (2023) Diagnostic performance of adding the optic nerve region assessed by optical coherence tomography to the diagnostic criteria for multiple sclerosis. Neurology 101(8):E784\u2013E793. https:\/\/doi.org\/10.1212\/WNL.0000000000207507","journal-title":"Neurology"},{"issue":"4","key":"12801_CR13","doi-asserted-by":"publisher","first-page":"E482","DOI":"10.1212\/WNL.0000000000011339","volume":"96","author":"A Vidal-Jordana","year":"2021","unstructured":"Vidal-Jordana A et al (2021) Optic nerve topography in multiple sclerosis diagnosis: the utility of visual evoked potentials. Neurology 96(4):E482\u2013E490. https:\/\/doi.org\/10.1212\/WNL.0000000000011339","journal-title":"Neurology"},{"issue":"3","key":"12801_CR14","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1159\/000503304","volume":"63","author":"G Pihl-Jensen","year":"2020","unstructured":"Pihl-Jensen G, Ivanov I, Hinze D, Trauzettel-Klosinski S, Frederiksen JL (2020) Sensitive assessment of acute optic neuritis by a new, digital flicker test. Ophthalmic Res 63(3):332\u2013340. https:\/\/doi.org\/10.1159\/000503304","journal-title":"Ophthalmic Res"},{"issue":"Pt 7","key":"12801_CR15","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1093\/brain\/awv105","volume":"138","author":"M Tintore","year":"2015","unstructured":"Tintore M et al (2015) Defining high, medium and low impact prognostic factors for developing multiple sclerosis. Brain 138(Pt 7):1863\u20131874. https:\/\/doi.org\/10.1093\/brain\/awv105","journal-title":"Brain"},{"issue":"6","key":"12801_CR16","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1212\/01.wnl.0000237354.10144.ec","volume":"67","author":"M Tintore","year":"2006","unstructured":"Tintore M et al (2006) Baseline MRI predicts future attacks and disability in clinically isolated syndromes. Neurology 67(6):968\u2013972. https:\/\/doi.org\/10.1212\/01.wnl.0000237354.10144.ec","journal-title":"Neurology"},{"issue":"2","key":"12801_CR17","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/ana.22366","volume":"69","author":"CH Polman","year":"2011","unstructured":"Polman CH et al (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 69(2):292\u2013302. https:\/\/doi.org\/10.1002\/ana.22366","journal-title":"Ann Neurol"},{"key":"12801_CR18","doi-asserted-by":"publisher","DOI":"10.1177\/13524585241233999","author":"AE Miller","year":"2024","unstructured":"Miller AE (2024) Dissemination in time as a requirement for diagnosis of multiple sclerosis: time for a change? Mult Scler. https:\/\/doi.org\/10.1177\/13524585241233999","journal-title":"Mult Scler"},{"issue":"6","key":"12801_CR19","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1002\/ana.20851","volume":"59","author":"F Costello","year":"2006","unstructured":"Costello F et al (2006) Quantifying axonal loss after optic neuritis with optical coherence tomography. Ann Neurol 59(6):963\u2013969. https:\/\/doi.org\/10.1002\/ana.20851","journal-title":"Ann Neurol"},{"key":"12801_CR20","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.cnp.2019.03.002","volume":"4","author":"JL Barton","year":"2019","unstructured":"Barton JL, Garber JY, Klistorner A, Barnett MH (2019) The electrophysiological assessment of visual function in multiple sclerosis. Clin Neurophysiol Pract 4:90\u201396. https:\/\/doi.org\/10.1016\/j.cnp.2019.03.002","journal-title":"Clin Neurophysiol Pract"},{"issue":"12","key":"12801_CR21","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1007\/s40263-018-0575-8","volume":"32","author":"A Klistorner","year":"2018","unstructured":"Klistorner A et al (2018) Assessment of opicinumab in acute optic neuritis using multifocal visual evoked potential. CNS Drugs 32(12):1159\u20131171. https:\/\/doi.org\/10.1007\/s40263-018-0575-8","journal-title":"CNS Drugs"},{"key":"12801_CR22","doi-asserted-by":"publisher","DOI":"10.1177\/1352458520975732","author":"G Pihl-Jensen","year":"2020","unstructured":"Pihl-Jensen G, Wanscher B, Frederiksen J (2020) Multifocal visual evoked potential evaluation for diagnosis of acute optic neuritis and for prediction of visual outcome and ganglion cell layer thinning following optic neuritis. Mult Scler. https:\/\/doi.org\/10.1177\/1352458520975732","journal-title":"Mult Scler"},{"issue":"5","key":"12801_CR23","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1002\/ana.25462","volume":"85","author":"RC Nolan-Kenney","year":"2019","unstructured":"Nolan-Kenney RC et al (2019) Optimal intereye difference thresholds by optical coherence tomography in multiple sclerosis: an international study. Ann Neurol 85(5):618\u2013629. https:\/\/doi.org\/10.1002\/ana.25462","journal-title":"Ann Neurol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-024-12801-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-024-12801-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-024-12801-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T16:40:16Z","timestamp":1739637616000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-024-12801-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,15]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["12801"],"URL":"https:\/\/doi.org\/10.1007\/s00415-024-12801-7","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,15]]},"assertion":[{"value":"30 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Gorm Pihl-Jensen has no conflicts of interest.\u00a0Jette Frederiksen has received no funding to support the presented work. She has served on scientific advisory boards for and received funding for travel related to these activities as well as honoraria from Merck Serono, Sanofi-Aventis, Roche, Novartis and Chiesi.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"131"}}